Latest Drugs Stories
Clean lines and an instinctive user interface frames a practical prescription management tool for consumers on-the-go NEW YORK, March 8, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today announced they have launched the Drugs.com Medication Guide, a mobile app to facilitate patient engagement in their own medication management. The "Drugs.com Medication Guide" app is now available as a free download on the popular iOS and Android mobile platforms....
OTTAWA, March 7, 2013 /CNW/ - Following the death of a child enrolled in a clinical trial for the drug Sensipar in the United States, Health Canada is reminding healthcare professionals and consumers that Sensipar is not approved for use in patients under 18 years of age. Sensipar (cinacalcet) is used for treating disorders of the parathyroid gland that result in high blood calcium levels. Amgen, the manufacturer of Sensipar, recently halted all pediatric clinical trials of...
New Prescription Service Powered by VetSource Pharmacy Makes Caring for Pets Easier Than Ever JERSEY CITY, N.J., March 7, 2013 /PRNewswire/ -- Quidsi, Inc. today announced the addition of direct access to pet medications on Wag.com through VetSource Pharmacy. The collaboration with VetSource, a fully licensed, Vet VIPPS certified pet pharmacy, marks the first time that prescription medications are available through a major online retailer with a comprehensive selection of pet...
Patients Benefit from Competitive Rx Drug Marketplace DALLAS, March 7, 2013 /PRNewswire-USNewswire/ -- As drug coverage increases as a result of expanded health insurance and Medicaid coverage under the Affordable Care Act, unnecessary regulations will increase prescription drug costs, according to a new study from the National Center for Policy Analysis (NCPA). (Logo: http://photos.prnewswire.com/prnh/20130225/DC65817LOGO) "Sixty percent of all Americans take a prescription drug...
An Essential reference for every family EASTON, Md, March 6, 2013 /PRNewswire-iReach/ -- AVAILABLE WITHOUT A PRESCRIPTION, AN ESSENTIAL REFERENCE FOR EVERY FAMILY FOR MORE INFORMATION Contact: James J Rybacki, Pharm.D. (410) 820-5865 March Sixth, 2013 Easton, Maryland www.EssentialGuideToPrescriptionDrugs.com MORE THAN 2 MILLION SOLD in previous editions! THE ESSENTIAL GUIDE TO PRESCRIPTION DRUGS 12 TOP MEDS OF 2012 Crucial info, key interactions, do's &...
Free program provides discounted prescriptions and healthcare services for constituents while generating revenue for participating counties Jackson, Miss. (PRWEB) March 04, 2013 The Mississippi Association of Supervisors (MAS) announced today that it has endorsed the Coast2Coast Rx discount prescription program. Boards of Supervisors in 11 Mississippi counties have vetted and approved the program which is free to both counties and citizens. The program also has the distinction of creating...
Clear Majority Opposes Prescription-Only PSE Requirements WASHINGTON, March 4, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Indiana voters conducted by The Polling Company and supported by CHPA. The poll, which surveyed 607 Hoosiers on February 4-6(th), found that a 65 percent majority of Hoosiers opposed changing state law to require a doctor's prescription for cold and allergy medicines...
ATLANTA, Feb. 27, 2013 /PRNewswire-USNewswire/ -- Makers of innovative biologics have legitimate reason to sound alarms about automatic substitution of biosimilars that have not proven their interchangeability - and it's not just because of the potential impact to their bottom line. That point was driven home by the recent recall of Affymax Inc. and Takeda Pharmaceutical Co. Ltd.'s anemia drug Omontys (peginesatide), according to BioWorld. (Logo:...
SAN DIEGO, Feb. 27, 2013 /PRNewswire/ -- MedVantx, Inc., the company that created the first ever controlled access to generic samples in US physician offices, today highlighted it's MedStart Connect program as a solution to the problem specified in a recent study published in JAMA Internal Medicine. In the study, researchers reported that changes in pill color that often occur during the prescription refill process significantly increase the odds of medication non-adherence. The...
redOrbit Staff & Wire Reports - Your Universe Online Officials with the US Food and Drug Administration (FDA) have halted a trial of the thyroid drug Sensipar following the death of a 14-year-old patient during clinical trials, various media outlets reported Tuesday. According to the Associated Press (AP), officials from the regulatory agency are still gathering information about the incident. However, in the meantime they have ordered the drug’s manufacturer, biopharmaceutical...
